title: Leukemia risk models in primary myelofibrosis: an International Working Group study.
authors.forename: A
authors.initials: A
authors.lastname: Tefferi
authors.forename: A
authors.initials: A
authors.lastname: Pardanani
authors.forename: N
authors.initials: N
authors.lastname: Gangat
authors.forename: K H
authors.initials: KH
authors.lastname: Begna
authors.forename: C A
authors.initials: CA
authors.lastname: Hanson
authors.forename: D L
authors.initials: DL
authors.lastname: Van Dyke
authors.forename: D
authors.initials: D
authors.lastname: Caramazza
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.forename: E
authors.initials: E
authors.lastname: Morra
authors.forename: M
authors.initials: M
authors.lastname: Cazzola
authors.forename: A
authors.initials: A
authors.lastname: Pereira
authors.forename: F
authors.initials: F
authors.lastname: Cervantes
authors.forename: F
authors.initials: F
authors.lastname: Passamonti
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007390:International Agencies; D007621:Karyotyping; D007938:Leukemia / Q000209:etiology* / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D055728:Primary Myelofibrosis / Q000150:complications* / Q000401:mortality* / Q000628:therapy; D012372:ROC Curve; D012307:Risk Factors; D015996:Survival Rate; D055815:Young Adult